160 related articles for article (PubMed ID: 11809591)
1. The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA.
Akyol M; Celik VK; Ozcelik S; Polat M; Marufihah M; Atalay A
Eur J Dermatol; 2002; 12(1):24-6. PubMed ID: 11809591
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
4. Response of vitiligo to narrowband ultraviolet B and oral antioxidants.
Elgoweini M; Nour El Din N
J Clin Pharmacol; 2009 Jul; 49(7):852-5. PubMed ID: 19553407
[TBL] [Abstract][Full Text] [Related]
5. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
[TBL] [Abstract][Full Text] [Related]
6. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
7. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet A.
Abdel-Naser MB; El-Khateeb EA; Sallam TH; Habib MA
Clin Exp Dermatol; 2006 Jul; 31(4):571-5. PubMed ID: 16716165
[TBL] [Abstract][Full Text] [Related]
9. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
10. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.
Hegyi V; Petrovajová M; Novotný M
Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185
[TBL] [Abstract][Full Text] [Related]
11. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.
El Mofty M; Mostafa W; Esmat S; Youssef R; Azzam O; Hunter N; El Hanafi G; Fawzi M
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):6-11. PubMed ID: 16436175
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriol and PUVA as treatment for vitiligo.
Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
[TBL] [Abstract][Full Text] [Related]
13. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
Abdel-Naser MB; Hann SK; Bystryn JC
Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
15. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
16. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
Vussuki E; Ziv M; Rosenman D; David M
Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
[TBL] [Abstract][Full Text] [Related]
17. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
Wackernagel A; Legat FJ; Hofer A; Quehenberger F; Kerl H; Wolf P
Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
[TBL] [Abstract][Full Text] [Related]
18. [New aspects on vitamin D3 ointment: vitamin D3 therapy for vitiligo].
Onita A
Clin Calcium; 2004 Oct; 14(10):137-40. PubMed ID: 15577147
[TBL] [Abstract][Full Text] [Related]
19. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
Lee Y; Seo YJ; Lee JH; Park JK
Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
[TBL] [Abstract][Full Text] [Related]
20. Autologous cultured melanocytes in vitiligo treatment.
Czajkowski R; Placek W; Drewa T; Kowaliszyn B; Sir J; Weiss W
Dermatol Surg; 2007 Sep; 33(9):1027-36; discussion 1035-6. PubMed ID: 17760593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
